- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04460742
CAPABLE Transitions: A Home Health-Based Intervention for the Hospital or Post-Acute Care Facility-to-Home Transition
CAPABLE Transitions: A Randomized, Unblinded, 60-Subject Clinical Trial of an Occupational Therapy-Led In-Home Intervention to Help Older Adults Transition to Their Homes Following Hospital or Post-Acute Care Facility Discharge
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study is a randomized, care-as-usual (CAU)-comparator, unblinded clinical trial of an occupational therapy (OT)-led in-home intervention designed to help older adults successfully return to and remain in their homes following discharge from a hospital or post-acute care facility (e.g., skilled nursing or inpatient rehabilitation facilities). This intervention is called CAPABLE Transitions. In total, 60 adults (36 in the intervention arm, 24 in the CAU arm) aged 65 years and older recently discharged from a hospital or post-acute care facility and admitted to a Medicare-certified home health agency (CHHA) with and without dementia will be recruited. This pilot study's main outcomes relate to the feasibility of the study. These outcomes include study recruitment and retention, fidelity to and perceived benefit of the intervention, and data completeness with regard to clinical outcomes (e.g., home time, quality of life, and health care utilization).
This study will recruit English-speaking adults aged 65 years and older who live in the Rochester region and are admitted to a CHHA following a hospital or post-acute care facility stay. There are two treatment groups. The intervention group will receive CAPABLE Transitions as well as CHHA CAU services. The CAU group will receive CHHA CAU services, which can include nursing, health aide, medical social work, and occupational, physical, and speech therapy services. CHHA clinicians will determine the types and duration of CHHA services that the study participants receive; these services will be completely independent from the research study.
Assessment interviews will be conducted at baseline as well as at three and six month follow-up. Interviews will assess sociodemographics, health and functioning, mental health and cognitive functioning, home environment, medical services use, and intervention feedback. Information also will be extracted on medical conditions, medications, communication with providers, and services utilization from participants' medical records.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- admitted to Medicare-certified home health agency following discharge from a hospital, inpatient rehabilitation facility, or skilled nursing facility
- live in Rochester, NY region
- aged 65 years or older
- English-speaking
Exclusion Criteria:
- plan to move within one year
- has a terminal diagnosis (e.g., < 1-year life expectancy, in hospice)
- receiving active cancer treatment (active treatment includes surgery or a course of radiation or chemotherapy; it does not include long-term maintenance treatment such as daily hormonal treatment of prostate cancer)
- inability or unwillingness of individual or legal guardian/representative to give written informed consent or assent
- has been discharged from a hospital or post-acute care facility for more than 28 days
- are COVID-19 positive, have suspected COVID-19 infection, or resides with a person who is COVID-19 positive or has suspected COVID-19
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CAPABLE Transitions
Older adults admitted to University of Rochester Medicine Home Care with and without dementia will receive care as usual as well as CAPABLE-trained occupational therapy, registered nurse, and handyman services delivered over 3-4 months.
|
The CAPABLE Transitions intervention group will receive an occupational therapy-led multidisciplinary in-home intervention in which the study occupational therapist (<6 visits), registered nurse (<5 visits), and handyman (<2 visits) work with participants over 3-4 months.
This intervention group also will receive home health agency care as usual services.
CAPABLE Transitions in embedded within a home health agency and includes a care transitions emphasis.
Both the CAPABLE Transitions intervention and care as usual treatment arms will receive home health agency care as usual services, which can include nursing, health aide, medical social work, and occupational, physical, and speech therapy services.
Home health agency clinicians will determine the types and duration of CHHA services that the study participants receive; these services will be completely independent from the research study.
|
Active Comparator: Care As Usual
Older adults admitted to University of Rochester Medicine Home Care (a Medicare-certified home health agency) with and without dementia will receive care as usual.
|
Both the CAPABLE Transitions intervention and care as usual treatment arms will receive home health agency care as usual services, which can include nursing, health aide, medical social work, and occupational, physical, and speech therapy services.
Home health agency clinicians will determine the types and duration of CHHA services that the study participants receive; these services will be completely independent from the research study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Critical Tasks Completed
Time Frame: Throughout Study Intervention, an average of 5 months
|
The study will review audio recordings and study interventionists' documentation to examine fidelity to the intervention and score whether the interventionists completed the central tasks of CAPABLE Transitions.
The study will score completion of the critical components as "yes" or "no" and this outcome will be reported as the proportion of critical components of the CAPABLE Transitions intervention that were completed by the occupational therapist and registered nurse.
|
Throughout Study Intervention, an average of 5 months
|
Percentage of Participants Screened as Eligible
Time Frame: For each potential participant, this outcome is determined prior to possible study enrollment.
|
The study will monitor how many older adults are screened and satisfy the eligibility criteria.
|
For each potential participant, this outcome is determined prior to possible study enrollment.
|
Percentage of Screened Participants That Enroll
Time Frame: This outcome is determined at the time of study enrollment.
|
The study will monitor how many older adults who satisfy the eligibility criteria are enrolled in the study.
|
This outcome is determined at the time of study enrollment.
|
Percentage of Enrolled Participants That Are Retained
Time Frame: 6 months
|
The study will monitor the percentage of participants that complete the study.
|
6 months
|
Percentage of Participants Who Perceive a Benefit From the Intervention
Time Frame: 3 months
|
Participants and study partners will be asked Likert-item response survey questions to assess the perceived benefit and burdensomeness of the intervention.
|
3 months
|
Percentage of Participants Who Perceive a Benefit From the Intervention
Time Frame: 6 months
|
Participants and study partners will be asked Likert-item response survey questions to assess the perceived benefit and burdensomeness of the intervention.
|
6 months
|
Data Completeness on Clinical Outcomes
Time Frame: 3 months
|
The study will monitor the percentage of participants who have complete information on home time, quality of life, and health services utilization at 3 months.
|
3 months
|
Data Completeness on Clinical Outcomes
Time Frame: 6 months
|
The study will monitor the percentage of participants who have complete information on home time, quality of life, and health services utilization at 6 months.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Home Time in Days (From the Baseline to 3 Month Period)
Time Frame: Baseline to Month 3 (3 months)
|
Home time is the number of days participants spend alive in non-institutional settings (e.g., nursing homes and hospitals).
The study will report the participants' home time from baseline to 3 months of follow-up.
|
Baseline to Month 3 (3 months)
|
Home Time in Days (From the 3 to 6 Month Period)
Time Frame: Month 3 to Month 6 (3 months)
|
Home time is the number of days participants spend alive in non-institutional settings (e.g., nursing homes and hospitals).
The study will report the participants' home time from 3 to 6 months of follow-up.
|
Month 3 to Month 6 (3 months)
|
Mean Change in Quality of Life Using EQ-5D-5L (Unabbreviated Title)
Time Frame: 3 months
|
The study will examine quality of life (EQ-5D-5L) among study participants at 3 months of follow-up (positive scores indicate improvement from baseline). Rating: mobility, self-care, usual activities, pain/discomfort and anxiety/depression, each with 1 as lowest score and 5 as highest score: no problems, slight problems, moderate problems, severe problems and extreme problems, where higher scores indicate worse outcome. The EQ VAS question records the patient's self-rated health on a vertical visual analogue scale from 0 to 100, where the endpoints are labelled 'The best health you can imagine' (score=100) and 'The worst health you can imagine' (score=0). Therefore higher scores may indicate better outcomes. |
3 months
|
Mean Change in Quality of Life Using EQ-5D-5L (Unabbreviated Title)
Time Frame: 6 months
|
The study will examine quality of life (EQ-5D-5L) among study participants at 6 months of follow-up (positive scores indicate improvement from baseline). Rating: mobility, self-care, usual activities, pain/discomfort and anxiety/depression, each with 1 as lowest score and 5 as highest score: no problems, slight problems, moderate problems, severe problems and extreme problems, where higher scores indicate worse outcome. The EQ VAS question records the patient's self-rated health on a vertical visual analogue scale from 0 to 100, where the endpoints are labelled 'The best health you can imagine' (score=100) and 'The worst health you can imagine' (score=0). Therefore higher scores may indicate better outcomes. |
6 months
|
Health Services Use, Percentage
Time Frame: Baseline to Month 3 (3 months)
|
The study will examine the percentage of participants who went to the emergency department, were hospitalized, and were admitted to a skilled nursing facility from baseline to 3 months of follow-up.
|
Baseline to Month 3 (3 months)
|
Health Services Use, Percentage
Time Frame: Month 3 to Month 6 (3 months)
|
The study will examine the percentage of participants who went to the emergency department, were hospitalized, and were admitted to a skilled nursing facility from 3 to 6 months of follow-up.
|
Month 3 to Month 6 (3 months)
|
Health Services Use, Mean
Time Frame: Baseline to Month 3 (3 months)
|
The study will tabulate the mean number of times participants went to the emergency department, were hospitalized, and were admitted to a skilled nursing facility from baseline to 3 months of follow-up.
|
Baseline to Month 3 (3 months)
|
Health Services Use, Mean
Time Frame: Month 3 to Month 6 (3 months)
|
The study will tabulate the mean number of times participants went to the emergency department, were hospitalized, and were admitted to a skilled nursing facility from 3 to 6 months of follow-up.
|
Month 3 to Month 6 (3 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Adam Simning, MD, PhD, University of Rochester
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00004519
- 5K23AG058757-02 (U.S. NIH Grant/Contract)
- 3 K 23 AG058757-02S1 (Other Grant/Funding Number: National Institute of Aging)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on CAPABLE Transitions
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingDepression | Quality of Life | End Stage Renal Disease | Disability PhysicalUnited States
-
Istituti Clinici Scientifici Maugeri SpAUniversity of Pavia; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsCompletedStomach Cancer | Breast Cancer | Head and Neck Cancer | Lung Cancer | Thyroid Cancer | Renal Cell Carcinoma Metastatic | Ovary CancerItaly
-
Johns Hopkins UniversityNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedDepression | Quality of Life | Caregiver Burden | Mild Cognitive Impairment | Disability Physical | Dementia, Mild | Impairment, CognitiveUnited States
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RecruitingDisability PhysicalUnited States
-
Johns Hopkins UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Completed
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedQuality of LifeUnited States
-
Karolinska InstitutetSwedish Council for Working Life and Social Research; Kamprad Family FoundationCompleted
-
Brigham and Women's HospitalAgency for Healthcare Research and Quality (AHRQ)Not yet recruitingHeart Failure | Diabetes Mellitus | Diabetes | Chronic Kidney Diseases | Congestive Heart Failure
-
Auburn UniversityCompleted
-
Abbott Medical DevicesCompletedChronic PainUnited States